BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27562474)

  • 1. Examining the prevalence of metabolic syndrome among overweight/obese African-American breast cancer survivors vs. matched non-cancer controls.
    Sheean P; Liang H; Schiffer L; Arroyo C; Stolley M
    J Cancer Surviv; 2017 Feb; 11(1):102-110. PubMed ID: 27562474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the prevalence of compromised bone health among overweight and obese African-American breast cancer survivors: a case-control study.
    Sheean P; Liang H; Schiffer L; Arroyo C; Troy K; Stolley M
    J Cancer Surviv; 2016 Feb; 10(1):21-30. PubMed ID: 25820976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
    Gaillard T; Schuster D; Osei K
    Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
    Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
    Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic syndrome in postmenopausal breast cancer survivors].
    Nahas EA; de Almeida Bda R; Buttros Dde A; Véspoli Hde L; Uemura G; Nahas-Neto J
    Rev Bras Ginecol Obstet; 2012 Dec; 34(12):555-62. PubMed ID: 23329285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women.
    Kabat GC; Kim MY; Lee JS; Ho GY; Going SB; Beebe-Dimmer J; Manson JE; Chlebowski RT; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1730-1735. PubMed ID: 28939589
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls.
    Lohmann AE; Ennis M; Taylor SK; Goodwin PJ
    Breast Cancer Res Treat; 2017 Jul; 164(2):451-460. PubMed ID: 28444534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and mammographic breast density in a racially diverse and predominantly immigrant sample of women.
    Tehranifar P; Protacio A; Schmitt KM; Desperito E; Oskar S; Potter AJ; Engmann NJ; Terry MB
    Cancer Causes Control; 2015 Oct; 26(10):1393-403. PubMed ID: 26169301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study.
    Bao PP; Zheng Y; Nechuta S; Gu K; Cai H; Peng P; Shu XO; Lu W
    Cancer Causes Control; 2013 Sep; 24(9):1747-56. PubMed ID: 23860950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Metabolic Syndrome and Immunohistochemical Profile at Breast Cancer Diagnosis in Postmenopausal Women.
    Motoki AH; Buttros DAB; Gaspar AL; Almeida-Filho BS; Carvalho-Pessoa E; Vespoli HDL; Nahas-Neto J; Nahas EAP
    Clin Breast Cancer; 2022 Feb; 22(2):e253-e261. PubMed ID: 34465534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients.
    Crispo A; Augustin LSA; Luongo A; Calderaio C; Breda J; Coluccia S; Calabrese A; Marrazzo V; Giannatiempo R; Trasacco P; Palumbo E; Vitale S; Porciello G; Di Gennaro P; Caputo R; Buono G; Vernieri C; Schettini F; Grimaldi M; Nocerino F; Celentano E; Amore A; Giuliano M; De Placido P; De Angelis C; Bianco R; De Laurentiis M; La Vecchia C; Arpino G
    Sci Rep; 2023 Dec; 13(1):21208. PubMed ID: 38040773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and elevated C-reactive protein in breast cancer survivors on adjuvant hormone therapy.
    Thomson CA; Thompson PA; Wright-Bea J; Nardi E; Frey GR; Stopeck A
    J Womens Health (Larchmt); 2009 Dec; 18(12):2041-7. PubMed ID: 20044868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study.
    Buono G; Crispo A; Giuliano M; De Angelis C; Schettini F; Forestieri V; Lauria R; De Laurentiis M; De Placido P; Rea CG; Pacilio C; Esposito E; Grimaldi M; Nocerino F; Porciello G; Giudice A; Amore A; Minopoli A; Botti G; De Placido S; Trivedi MV; Arpino G
    Breast Cancer Res Treat; 2020 Jul; 182(2):401-409. PubMed ID: 32500397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey.
    de Ferranti SD; Gauvreau K; Ludwig DS; Neufeld EJ; Newburger JW; Rifai N
    Circulation; 2004 Oct; 110(16):2494-7. PubMed ID: 15477412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and outcomes following early-stage breast cancer.
    Calip GS; Malone KE; Gralow JR; Stergachis A; Hubbard RA; Boudreau DM
    Breast Cancer Res Treat; 2014 Nov; 148(2):363-77. PubMed ID: 25301086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Predictors of Low Serum 25-Hydroxyvitamin D among Female African-American Breast Cancer Survivors.
    Sheean P; Arroyo C; Woo J; Schiffer L; Stolley M
    J Acad Nutr Diet; 2018 Apr; 118(4):568-577. PubMed ID: 29305131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between metabolic syndrome, insulin resistance, and IGF-1 in breast cancer survivors of DIANA-5 study.
    De Santi M; Annibalini G; Marano G; Biganzoli G; Venturelli E; Pellegrini M; Lucertini F; Brandi G; Biganzoli E; Barbieri E; Villarini A
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8639-8648. PubMed ID: 37106164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy.
    Dieli-Conwright CM; Wong L; Waliany S; Bernstein L; Salehian B; Mortimer JE
    Cancer; 2016 Sep; 122(17):2646-53. PubMed ID: 27219902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional Status of Breast Cancer Survivors 1 Year after Diagnosis: A Preliminary Analysis from the Malaysian Breast Cancer Survivorship Cohort Study.
    Majid HA; Keow LP; Islam T; Su TT; Cantwell M; Taib NA;
    J Acad Nutr Diet; 2018 Apr; 118(4):705-713. PubMed ID: 28756991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.